Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last hours
Enjoy this offer
* See conditions under "Our services"

Valuation: Getinge AB

Market Cap 52.69B 5.54B 4.81B 4.43B 4.17B 7.81B 524B 7.9B 20.43B 257B 20.8B 20.35B 897B P/E 2026 *
18.6x
P/E 2027 * 15.9x
Enterprise Value 61.1B 6.43B 5.58B 5.14B 4.83B 9.06B 607B 9.16B 23.69B 298B 24.12B 23.6B 1,040B EV / Sales 2026 *
1.75x
EV / Sales 2027 * 1.61x
Free-Float
78.61%
Yield 2026 *
2.61%
Yield 2027 * 2.84%
1 day-13.69%
3 months-13.69%
6 months-9.28%
Current year-9.28%
Current year 20.05
Extreme 20.05
24.75
1 year 18.82
Extreme 18.82
24.75
3 years 15.62
Extreme 15.62
24.75
5 years 15.62
Extreme 15.62
48.01
10 years 8.75
Extreme 8.75
48.01
Manager TitleAgeSince
Chief Executive Officer 54 01/05/2017
Director of Finance/CFO - 31/03/2024
Compliance Officer 47 01/10/2020
Director TitleAgeSince
Director/Board Member 70 01/01/2007
Chairman 75 -
Chairman 65 23/04/2019
Change 5-day change 1-year change 3-year change Capi.($)
-13.69%-.--% - - 5.66B
-0.72%-1.53%+21.15%-6.29% 12.53B
+1.40%-3.68%+57.50%+25.60% 5.89B
+0.26%+0.92%-29.27%+16.32% 4.09B
-3.61%-6.28% - - 4.13B
-0.86%+0.84%-29.30%-25.13% 3.76B
+2.06%+3.54%-0.31%-59.62% 2.03B
-0.66%+6.56%+48.76%+217.99% 1.83B
-0.17%0.00%+57.81%-5.06% 1.56B
-0.23%-5.14%-17.11%-53.69% 1.26B
Average -1.62%-0.39%+13.65%+13.76% 4.12B
Weighted average by Cap. -2.18%-1.21%+16.10%+7.48%

Financials

2026 *2027 *
Net sales 34.91B 3.67B 3.19B 2.94B 2.76B 5.18B 347B 5.23B 13.54B 170B 13.78B 13.48B 594B 36.63B 3.85B 3.35B 3.08B 2.9B 5.43B 364B 5.49B 14.2B 179B 14.46B 14.15B 624B
Net income 2.81B 296M 257M 236M 222M 417M 27.93B 421M 1.09B 13.72B 1.11B 1.09B 47.84B 3.31B 348M 303M 279M 262M 491M 32.92B 497M 1.28B 16.17B 1.31B 1.28B 56.4B
Net Debt 8.41B 885M 769M 708M 665M 1.25B 83.59B 1.26B 3.26B 41.06B 3.32B 3.25B 143B 6.32B 665M 578M 532M 500M 937M 62.81B 948M 2.45B 30.85B 2.5B 2.44B 108B
Logo Getinge AB
Getinge AB is a Sweden-based company operating within healthcare sector. The Company provides hospitals and Life Science institutions with products and solutions aimed at improving clinical outcomes and optimizing workflows. The Company’s reporting segments have the following activities: Acute Care Therapies develops solutions for life-sustaining care in acute health conditions. Life Science offers a comprehensive range of equipment, technical expertise and prevention consultation contamination in pharmaceutical production, biomedical research, production of medical equipment and in various laboratory applications. Surgical Workflows offers products and services for the effective disinfection and sterilization of instruments used in operations, operating tables and others hardware for operating rooms and advanced IT systems for efficient and secure workflows in hospitals.
Employees
11,754
Trader
Investor
Global
Quality
ESG MSCI
B
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
10
Last Close Price
193.45SEK
Average target price
227.20SEK
Spread / Average Target
+17.45%

Quarterly revenue - Rate of surprise

LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!